Mandatory notification of trade – primary insider

Martin Hedlund, member of the Board of ContextVision has purchased shares in ContextVision. With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Martin Hedlund Relation to listed entity: […]
Read More

Mandatory notification of trade – primary insider

With reference to Section 4-2 of the Norwegian Securities Trading Act (“STA”), kindly note the following primary insider share transactions: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Olof Sandén Relation to listed entity: Chairman of the Board Trade: 15.000 shares Date: 08.11.2024 Average purchase price: NOK 4,83 per share Primary […]
Read More

Q3 interim report 2024 – Focus on internal efficiency and product development to drive long-term growth

Q3 Highlights Continuing integration with newly signed customers in Asia and North America. Close collaboration with the market to receive feedback from customers to strategically develop and enhance our products. Internal reorganization to strenghen our teams and become more effective regarding marketing and product development. Execution of roadmap for upcoming products. Q3 Financial Data Net […]
Read More

ContextVision publishes Webcast for Q3 2024

Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q3 2024 along the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.com/investors/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at  or visit our official website at www.contextvision.com. About ContextVision ContextVision is a medical technology software company specialized […]
Read More

Notice to the Extraordinary General Meeting in ContextVision AB (publ)

The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby invited to the Extraordinary General Meeting on Wednesday, 20 November 2024, at 11:00, at the company’s premises, Holländargatan 13, Stockholm. Participation and Notification etc Shareholders who wish to participate in the general meeting with the right to vote shall be recorded as shareholder in […]
Read More

ContextVision publishes Webcast for Q2 2024

Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision’s highlights from Q2 2024 along the financials for the quarter. The Webcast is available on ContextVision’s website following the link below: https://www.contextvision.com/investors/webcast/ For more details, contact ContextVision’s CFO, Richard Hallström at  or visit our official website at www.contextvision.com. About ContextVision ContextVision is a medical technology software company specialized […]
Read More

Q2 interim report 2024 – Strong cash position supports continued investment in Image and Data Quality

In the second quarter of 2024, we have signed new customers in North America and Asia, and we are continuing our investments in both image quality and data quality. Our cash flow remains stable, with a good cash position, and we are confident that the investments we are making now will drive long-term growth.
Read More

ContextVision enters Data Quality market with organ-specific enhancements

Expanding product pipeline from Image Quality to Data Quality ContextVision is committed to expanding its Image Quality business, which today focuses on enhancing medical image quality for a radiologists’ interpretation. Alongside, ContextVision is pioneering a new Data Quality business aimed at machine-aided interpretation. Data Quality is a natural extension of ContextVision’s Image Quality business that […]
Read More